Education
About Us
Working with TipRanks
Follow Us
Doximity (DOCS)
NYSE:DOCS
DOCS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$39.27 - $85.21
Previous CloseN/A
Volume296.07K
Average Volume (3M)1.58M
Market Cap
$13.31B
Enterprise Value$11.51B
Total Cash (Recent Filing)$840.97M
Total Debt (Recent Filing)$11.84M
Price to Earnings (P/E)61.0
Beta1.31
Next Earnings
Nov 06, 2025EPS Estimate
0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.36
Shares Outstanding136,400,250
10 Day Avg. Volume1,057,112
30 Day Avg. Volume1,579,324
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.87
Enterprise Value/Revenue19.52
Enterprise Value/Gross Profit21.65
Enterprise Value/Ebitda44.42
Forecast
1Y Price Target
$68.93Price Target Upside-2.96% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering16
Bulls Say, Bears Say
Bulls Say
Acquisition StrategyThe announced acquisition of Pathway AI, an AI clinical reference company, should enhance DOCS' strategy and further build the competitive moat.
Financial PerformanceDOCS' FY1Q results were strong, with revenue and EBITDA above expectations and guidance, driven by new product launches and the portal.
Product InnovationDOCS continues to innovate with new AI products, solidifying its position as a strategic partner in the bio-pharma industry.
Bears Say
Guidance ConservatismRevised FY'26 guidance continues to contemplate significant conservatism with implied revenue growth of ~7% year-over-year in the second half of FY'26.
Stock CompensationStock compensation dilution from Pathway acquisition and large incentive awards for AI development are expected to rise to high-teens percentage of revenue in FY'26-FY'27.
Doximity News
DOCS FAQ
What was Doximity’s price range in the past 12 months?
Doximity lowest stock price was $39.27 and its highest was $85.21 in the past 12 months.
What is Doximity’s market cap?
Doximity’s market cap is $13.31B.
When is Doximity’s upcoming earnings report date?
Doximity’s upcoming earnings report date is Nov 06, 2025 which is in 51 days.
How were Doximity’s earnings last quarter?
Doximity released its earnings results on Aug 07, 2025. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.302 by $0.058.
Is Doximity overvalued?
According to Wall Street analysts Doximity’s price is currently Overvalued.
Does Doximity pay dividends?
Doximity does not currently pay dividends.
What is Doximity’s EPS estimate?
Doximity’s EPS estimate is 0.38.
How many shares outstanding does Doximity have?
Doximity has 136,400,250 shares outstanding.
What happened to Doximity’s price movement after its last earnings report?
Doximity reported an EPS of $0.36 in its last earnings report, beating expectations of $0.302. Following the earnings report the stock price went up 13.715%.
Which hedge fund is a major shareholder of Doximity?
Currently, no hedge funds are holding shares in DOCS
Doximity Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$68.93 (-2.96% Downside)
$68.93 (-2.96% Downside)
Blogger Sentiment
Bullish
DOCS Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 148.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 7.8%
Last 30 Days ▲ 4.6%
Last 30 Days ▲ 4.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.84%
12-Months-Change
Fundamentals
Return on Equity
24.25%
Trailing 12-Months
Asset Growth
12.20%
Trailing 12-Months
Company Description
Doximity
Doximity (DOCS) is a leading digital platform for healthcare professionals in the United States, primarily serving physicians and healthcare providers. The company operates in the healthcare technology sector, offering a suite of tools that facilitate communication, collaboration, and access to medical information. Doximity's core products include a secure professional networking site, telehealth services, and a platform for continuous medical education, all designed to enhance the efficiency and effectiveness of healthcare delivery.
DOCS Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook with strong financial performance, significant user growth, and successful product launches. However, there are concerns regarding policy uncertainties and the lack of immediate revenue contribution from recent acquisitions.View all DOCS earnings summariesDOCS Revenue Breakdown
93.00% Subscription
7.00% Other
DOCS Stock 12 Month Forecast
Average Price Target
$68.93
▼(-2.96% Downside)
Technical Analysis
Omnicell
―
Evolent Health
―
Teladoc
―
Definitive Healthcare Corp
―
Tempus AI, Inc. Class A
―
Ownership Overview
2.42% Insiders
31.75% Mutual Funds
26.99% Other Institutional Investors
19.55% Public Companies and Individual Investors